Dr. Salman Ahmed
Therapeutic potentials of crocin in medication of neurological disorders
Journal title : Food and Chemical Toxicology
Publisher : Elsevier BV
Print ISSN : 0278-6915
Page Number : 111739
Journal volume : 145
321 Views Reviews Article
Neurological sicknesses are severe, multifactorial, debilitating disorders that may cause neurodegeneration. Neuroprotection protects the structure and capacity of neurons from affronts emerging from cell injuries instigated by an assortment of specialists or neurodegenerative diseases. Various neurodegenerative diseases, including Alzheimer's, Parkinson's, and epilepsy, afflict many people worldwide, with increasing age representing the leading risk factor. Crocin is a natural carotenoid compound with therapeutic potential in managing neurological disease. In this review, we focused on the therapeutic capabilities of Crocin as a neuroprotective agent. The general neuroprotective impact and the various conceivable essential components identified with Crocin have been examined. In light of the substantial proof indicating the neuro-pharmacological viability of Crocin to different exploratory standards, it is concluded that Crocin exerts direct antioxidant, antiapoptotic and anti-inflammatory activities by multiple signalling pathways. Besides, Crocin was found to elevate dopamine levels in the brain during the experimental model of Parkinson's disease. Thus, this compound has been demonstrated to be a promising option for treating neurodegenerative diseases with few adverse effects. It should be further considered as a potential contender for neuro-therapeutics, concentrating on the mechanistic and clinical evidence for its effects.
Article DOI & Crossmark Data
DOI : https://doi.org/10.1016/j.fct.2020.111739
Article Subject Details
Article Keywords Details
Article File
Full Text PDFArticle References
- (1). 10.1002/(SICI)1099-1573(200005)14:3<149::AID-PTR665>3.0.CO;2-5
- (2). 10.1016/j.pbb.2005.06.007
- (3). 10.1016/j.fct.2019.110646
- (4). 10.1016/j.biopha.2018.01.113
- (5). 10.3390/ijms20092313
- (6). 10.3390/ijms20225570
- (7). 10.1016/j.pbb.2015.10.011
- (8). 10.1016/j.biochi.2019.02.011
- (9). 10.14581/jer.15009
- (10). 10.1021/acschemneuro.7b00101
- (11). 10.3109/10520295.2014.890741
- (12). 10.1016/j.fitote.2011.06.001
- (13). 10.1016/j.ynstr.2018.05.003
- (14). 10.1080/10408398.2013.879467
- (15). 10.3389/fnins.2019.00249
- (16). 10.1159/000439026
- (17). 10.1111/jphp.12456
- (18). 10.3389/fnins.2019.00560
- (19). 10.1155/2018/4067597
- (20). 10.4103/1673-5374.253509
- (21). 10.4236/jbbs.2013.33031
- (22). 10.2174/1570159X13666150716165726
- (23). 10.1021/acs.jafc.6b04398
- (24). 10.1016/S0306-4522(00)00041-5
- (25). 10.1007/s00213-013-3293-4
- (26). 10.1021/jf300589c
- (27). 10.1016/j.ejphar.2011.05.012
- (28). 10.2478/s11658-013-0092-1
- (29). 10.1016/j.seizure.2013.04.015
- (30). 10.1161/01.STR.0000126044.83777.f4
- (31). 10.1007/s12565-018-0457-7
- (32). 10.1002/ptr.3011
- (33). 10.1002/ptr.3566
- (34). 10.1007/s11418-017-1150-1
- (35). 10.3389/fphar.2018.01555
- (36). 10.1016/j.pneurobio.2018.05.001
- (37). 10.1016/j.apjtb.2015.07.015
- (38). 10.1016/j.ynstr.2018.04.002
- (39). 10.3109/03639040903140589
- (40). 10.1016/j.phymed.2013.07.013
- (41). 10.1016/S2221-1691(13)60060-X
- (42). 10.3109/03639045.2014.902466
- (43). 10.1093/advances/nmz047
- (44). 10.1007/s10570-013-9970-y
- (45). 10.1155/2019/9454913
- (46). 10.3389/fnins.2019.00043
- (47). 10.1007/s11064-016-1905-1
- (48). 10.1016/j.brainresbull.2019.01.004
- (49). 10.2174/1570159X12666140923205715
- (50). 10.3389/fphar.2014.00147
- (51). 10.1016/j.ejphar.2010.09.003
- (52). 10.1016/j.bbagen.2006.11.012
- (53). 10.1155/2013/239854
- (54). 10.1016/j.bbadis.2004.06.008
- (55). 10.1016/j.lfs.2016.04.028
- (56). 10.1016/j.bbr.2006.06.005
- (57). 10.1016/j.bbr.2007.06.001
- (58). 10.1055/a-0732-5757
- (59). 10.1016/j.exer.2012.11.011
- (60). 10.1016/j.ijbiomac.2017.02.095
- (61). 10.1590/0004-282X20160131
- (62). 10.1016/j.neuro.2015.12.010
- (63). 10.4103/2221-1691.239426
- (64). 10.1007/s10495-010-0463-2
- (65). 10.1007/s00580-019-02981-4
- (66). 10.1016/j.phrs.2020.104730
- (67). 10.1002/cbf.2858
- (68). 10.2174/1381612825666190425163424
- (69). 10.3389/fphar.2018.00715
- (70). 10.3390/molecules24081583
- (71). 10.1016/S0024-3205(01)01357-1
- (72). 10.1016/j.jad.2014.11.035
- (73). 10.1016/S1734-1140(12)70735-1
- (74). 10.2174/092986707780597961
- (75). 10.1046/j.1528-1157.2001.042suppl.3008.x
- (76). 10.1016/j.phymed.2010.10.019
- (77). 10.2174/157015909787602823
- (78). 10.1016/j.jstrokecerebrovasdis.2012.10.008
- (79). 10.1016/j.neulet.2015.02.016
- (80). 10.1016/j.jphs.2017.08.007
- (81). 10.1038/aps.2010.186
- (82). 10.1016/j.ejphar.2010.09.081
- (83). 10.1007/s11655-010-0145-5
- (84). 10.3164/jcbn.11-01
- (85). 10.5853/jos.2016.00206
- (86). 10.1016/j.neuint.2015.07.011
- (87). 10.1016/j.ejmech.2017.09.068
- (88). 10.1186/s12979-018-0132-9
- (89). 10.3389/fphar.2019.00440
- (90). 10.1016/j.brainres.2006.12.064
More Article by Dr. Salman Ahmed
The seeds of cleome viscosa are used in traditional systems of medicine for the treatment of many diseases in asia. this study evaluated fixed oil from the seeds of cleome viscosa...
Plants have been used as medicine for the treatment of diseases for thousands of years. these herbal remedies, although natural, can cause some serious damaging effects on the vita...
The current study was conducted to explore the antiemetic activity of ten aromatic medicinal plants viz., carissa carandus l. (fruits), chichorium intybus l (flowers), cinnamum tam...
Crude methanol extracts of the leaves of adenanthera pavonina l., peltoforum roxburghii l, prosopis cineraria l., and prosopis juliflora dc., were evaluated for anti-emetic activit...